What defines an efficacious COVID-19 Vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2 by Hodgson, SH, Mansatta, K, Mallett, G, Harris, V, Emary, K, Pollard, AJ

Vaccine nationalism and internationalism: perspectives of COVID-19 vaccine trial participants in the United Kingdom by Vanderslott, S, Emary, K, te Water Naude, R, English, M, Thomas, T, Patrick-Smith, M, Henry, J, Douglas, N, Moore, M, Stuart, A, Hodgson, SH, Pollard, AJ

The collective voice of early phase COVID-19 vaccine trial participants: Insights for improving confidence in novel vaccines by Thomas, TM, Hodgson, SH, Emary, K, Patrick-Smith, M, Te Water Naude, R, Stuart, ASV, Henry, J, English, M, Moore, M, Douglas, N, Pollard, AJ, Vanderslott, S

Co-producing human and animal experimental subjects: exploring the views of UK COVID-19 vaccine trial participants on animal testing by Vanderslott, S, Palmer, A, Thomas, T, Greenhough, B, Stuart, A, Henry, JA, English, M, Naude, RDW, Patrick-Smith, M, Douglas, N, Moore, M, Hodgson, SH, Emary, KRW, Pollard, AJ

Standardization of the antibody-dependent respiratory burst assay with human neutrophils and Plasmodium falciparum malaria by Llewellyn, D, Miura, K, Fay, MP, Williams, AR, Murungi, LM, Shi, J, Hodgson, SH, Douglas, AD, Osier, FH, Fairhurst, RM, Diakite, M, Pleass, RJ, Long, CA, Draper, SJ

Incidental findings in UK healthy volunteers screened for a COVID-19 vaccine trial by Hodgson, SH, Iveson, P, Larwood, J, Roche, S, Morrison, H, Cosgrove, C, Galiza, E, Ikram, S, Lemm, N-M, Mehdipour, S, Owens, D, Pacurar, M, Schumacher, M, Shaw, RH, Faust, SN, Heath, PT, Pollard, AJ, Emary, KRW, Pollock, KM, Lazarus, R

Evaluation of the efficacy of chad63-mva vectored vaccines expressing circumsporozoite protein and me-trap against controlled human malaria infection in malaria-naive individuals by Hodgson, SH, Ewer, KJ, Bliss, CM, Edwards, NJ, Rampling, T, Anagnostou, NA, De Barra, E, Havelock, T, Bowyer, G, Poulton, ID, De Cassan, S, Longley, R, Illingworth, JJ, Douglas, AD, Mange, PB, Collins, KA, Roberts, R, Gerry, S, Berrie, E, Moyle, S, Colloca, S, Cortese, R, Sinden, RE, Gilbert, SC, Bejon, P, Lawrie, AM, Nicosia, A, Faust, SN, Hill, AV

Superior antibody immunogenicity of a viral-vectored RH5 blood-stage malaria vaccine in Tanzanian infants as compared to adults by Silk, SE, Kalinga, WF, Mtaka, IM, Lilolime, NS, Mpina, M, Milando, F, Ahmed, S, Diouf, A, Mkwepu, F, Simon, B, Athumani, T, Rashid, M, Mohammed, L, Lweno, O, Ali, AM, Nyaulingo, G, Mwalimu, B, Mswata, S, Mwamlima, TG, Barrett, JR, Wang, LT, Themistocleous, Y, King, LDW, Hodgson, SH, Payne, RO, Nielsen, CM, Lawrie, AM, Nugent, FL, Cho, J-S, Long, CA, Miura, K, Draper, SJ, Minassian, AM, Olotu, AI

Vaccination with Plasmodium vivax Duffy-binding protein inhibits parasite growth during controlled human malaria infection by Hou, M, Barrett, JR, Themistocleous, Y, Rawlinson, TA, Diouf, A, Martinez, FJ, Nielsen, CM, Lias, AM, King, LDW, Edwards, NJ, Greenwood, NM, Kingham, L, Poulton, I, Khozoee, B, Goh, C, Hodgson, SH, Mac lochlainn, D, Salkeld, J, Guillotte-Blisnick, M, Huon, C, Mohring, F, Reimer, JM, Chauhan, VS, Biswas, S, Lawrie, AM, Silk, SE, Minassian, AM, Draper, SJ, Mukherjee, P, Taylor, IJ, Cho, J, Nugent, FL, Long, CA, Moon, RW, Miura, K, Chitnis, CE

Development and internal validation of clinical prediction models for outcomes of complicated intra-abdominal infection by Ahmed, S, Bonnett, L, Melhuish, A, Adil, MT, Aggarwal, I, Ali, W, Bennett, J, Boldock, E, Burns, FA, Czarniak, E, Dennis, R, Flower, B, Fok, R, Goodman, AL, Halai, S, Hanna, T, Hashem, M, Hodgson, SH, Hughes, G, Hurndall, K-H, Hyland, R, Iqbal, MR, Jarchow-MacDonald, A, Kailavasan, M, Klimovskij, M, Laliotis, A, Lambourne, J, Lawday, S, Lee, F, Lindsey, B, Lund, JN, Mabayoje, DA, Malik, KI, Muir, A, Narula, HS, Ofor, U, Parsons, H, Pavelle, T, Prescott, K, Rajgopal, A, Roy, I, Sagar, J, Scarborough, C, Shaikh, S, Smart, CJ, Snape, S, Tabaqchali, MA, Tennakoon, A, Tilley, R, Vink, E